Skip to main content
Log in

Interpretive criteria for temocillin disk diffusion susceptibility testing

  • Originals
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

The susceptibility of 677 clinical bacterial isolates to temocillin was determined by broth microdilution and disk diffusion methods for the purpose of evaluating disks with three different temocillin concentrations and determining the temocillin disk diffusion interpretive criteria. The 60μg temocillin disk provided the highest interpretive accuracy (96.2 %), although the 30μg disk differed by having only three (1.2 %) additional minor interpretive errors. Based on available temocillin pharmacokinetics and recommended dosage schedules, the minimum inhibitory concentration breakpoints chosen were: ⩾ 32μg/ml = resistant and ⩽ 16μg/ml = susceptible. The corresponding disk diffusion zone diameter breakpoints for the 60μg disk were ⩽ 17 mm and ⩾ 21 mm; zone diameters of 18–20 mm were considered intermediate. For the 30μg disk these were ⩽ 15 mm, ⩾ 19 mm and 16–18 mm respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fuchs, P. C., Barry, A. L., Jones, R. N., Thornsberry, C.: Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains. Diagnostic Microbiology and Infectious Disease 1984, 2: 55–63.

    PubMed  Google Scholar 

  2. Greenwood, D., Cowlishaw, A., Eley, A.: In vitro activity of temocillin. A new beta-lactamase-stable penicillin active againstEnterobacteriaceae. Antimicrobial Agents and Chemotherapy 1982, 22: 198–200.

    PubMed  Google Scholar 

  3. Jules, K., Neu, H. C.: Antibacterial activity and betalactamase stability of temocillin. Antimicrobial Agents and Chemotherapy 1982, 22: 453–460.

    PubMed  Google Scholar 

  4. Slocombe, B., Basker, M. J., Bentley, P. H., Clayton, J. P., Cole, M., Comber, K. R., Dixon, R. A., Edmondson, R. A., Jackson, D., Merrikin, D. S., Sutherland, R.: BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. Antimicrobial Agents and Chemotherapy 1981, 20: 38–46.

    PubMed  Google Scholar 

  5. Verbist, L.: In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin. Antimicrobial Agents and Chemotherapy 1982, 22: 157–161.

    PubMed  Google Scholar 

  6. Plot, P., Van Dyck, E.: In vitro activity of BRL 17421 againstHaemophilus influenzae, Neisseria gonorrhoeae, andBranhamella catarrhalis. Antimicrobial Agents and Chemotherapy 1982, 21: 166–167.

    PubMed  Google Scholar 

  7. Yogev, R., Glogowski, W., Conner, E.: Comparative in vitro activity of temocillin (BRL 17421) and ampicillin againstHaemophilus influenzae type b. Antimicrobial Agents and Chemotherapy 1983, 23: 182–184.

    PubMed  Google Scholar 

  8. National Committee for Clinical Laboratory Standards: Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Tentative Standard M7-T. NCCLS, Villanova, PA, 1983.

    Google Scholar 

  9. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobic disk susceptibility tests. Tentative Standard M2-T3. NCCLS, Villanova, PA, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuchs, P.C., Barry, A.L., Thornsberry, C. et al. Interpretive criteria for temocillin disk diffusion susceptibility testing. Eur. J, Clin. Microbiol. 4, 30–33 (1985). https://doi.org/10.1007/BF02148656

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02148656

Keywords

Navigation